This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jönsson B Measurement of health outcome and associated costs in cardiovascular disease Eur Heart J 1997 17 (Suppl) 2–7
Jönsson B Cost-benefit of treating hypertension J Hypertens 1994 12 (Suppl 10) 65–70
Weinstein M, Stason WB Allocation of resources to manage hypertension N Engl J Med 1977 296 732–739
Johannesson M et alCost-effectiveness of treating hypertension in the elderly: an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-hypertension) J Int Med 1993 234 317–323
SBU—The Swedish Council on Technology Assessment in Health Care Moderately elevated blood pressure J Int Med 1995 238 (Suppl 737) 103–115
Jönsson B et alCost-effectiveness of cholesterol lowering, the results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J 1996 17 1001–1007
Johannesson M, Meltzer D, O’Conor RM Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of treatment of hypertension Med Dec Making 1997 17 382–389
Johannesson M et alCost-effectiveness of simvastatin treatment to lower cholesterol levels inpatients with coronary heart disease N Engl J Med 1997 336 332–336
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Jönsson, B., Buxton, M., Hertzman, P. et al. Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Hum Hypertens 15 (Suppl 1), S53–S56 (2001). https://doi.org/10.1038/sj.jhh.1001086
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001086
Keywords
This article is cited by
-
Coste-efectividad de atorvastatina en hipertensos con riesgo moderado: evaluación económica del estudio ASCOT-LLA
PharmacoEconomics Spanish Research Articles (2006)
-
The effects of cardiac events on quality of life and indirect costs
Journal of Human Hypertension (2001)